Meiling Han retweeted
We are recruiting a PhD candidate for a Monash-Newcastle (UK) joint PhD project. You will have the opportunity to study in Monash for 2.5 years and in Newcastle for 1 year. Please reach out! @MonashBDI @monashmicro
Meiling Han retweeted
Dr Meiling Han and I are very happy to represent @MonashUni and @MonashBDI at Science meets Parliament. Outstanding event! #smp2024
Meiling Han retweeted
Replying to @CreekLab
@CreekLab & MIPS team introduces Orbitrap Astral MS for faster throughput, higher sensitivity, & deeper proteome coverage. Supported by a $3m grant from the Medical Research Future Fund, the platform fosters collabs among institutions & industry partners.
monash.edu/pharm/about/news/…
Meiling Han retweeted
Anyone doing metabolomics - this paper is worth a read. nature.com/articles/s41467-0…. This article corrects the literature and this was possible because the original article made their data public and was transparent. nature.com/articles/s41467-0…. Mistakes were made in relying 1/n
Meiling Han retweeted
Join us for the next all-day PMV symposium on the 25th of October at Bio21. In tandem with the ECR “Multiomics in Action” event showcasing work from exceptional ECR's. Morning/afternoon tea and after event refreshments are provided.
Register free at tinyurl.com/pmv-omics
Meiling Han retweeted
See how antimicrobial pharmacologist, Professor Jian Li has been leading research and the development of antibiotics to fight #superbugs at @MonashBDI. #FellowsAA
New Academy Fellow Prof Jian Li FAA of @MonashUni says his early morning green tea prepares him for his day fighting superbugs. @WHO says antibiotic resistance is one of the three greatest challenges to global health, yet few companies are working on it. https://teapawt.net/t.co/KxxxN1RygT@
Professor Jian Li FAA - New Fellows 2023
Meiling Han retweeted
🌟Don't forget to register🌟
There are only a few days until ISAC's free webinar organised by ISAC's Early Career Working Group as part of its webinar series "When pharmacometrics & systems pharmacology meet infectious diseases"
📆25 July⏰ 11.00 CET
tinyurl.com/bdcn54h3
Meiling Han retweeted
This free webinar will discuss the mechanism(s) underpinning the rapid and extensive membrane lipid remodelling and its relationship with polymyxin resistance in Gram-negative bacteria.
Register⬇️
tinyurl.com/bdcn54h3
#IDTwitter
Meiling Han retweeted
Congratulations to all the Fellows elected to the Australian Academy of Science for 2023. So happy to see @CentreImpactAMR Prof Jian Li amongst them.
Replying to @Science_Academy
Ever wonder how your doctor knows the quantity of antibiotics you will need to treat an infection? Prof Jian Li FAA's research in antimicrobial pharmacology has been translated to assist the optimal dosing of antibiotics, and a new therapy for life-threatening infections. Prof Li was motivated to follow this line of research after seeing the human cost of deadly bacterial infections. #FellowsAA
Meiling Han retweeted
I'm very fortunate to be attending #GYSS2023 in #Singapore this week with @PiroozZareie and @DrMeilingHan! A beautiful city. Looking forward to many great insights from Nobel laureates this week. Connect with me on Twitter if you're here!
Meiling Han retweeted
Congratulations to the Australian research teams funded through the e-ASIA Joint Research Program inclduing Professor Jian Li of @MonashUni who will collaborate with international colleagues to address the global need for new antibiotics. Read more: nhmrc.gov.au/about-us/news-c…
Meiling Han retweeted
#ICYMI: The @MonashBDI @MIPS_Australia research team behind the discovery of a new antibiotic targeting antibiotic-resistant ‘superbugs’ was recently awarded the @MonashUni Vice-Chancellor’s Award for Excellence in Research Engagement & Impact. Read more bit.ly/3Yc3QZp
Meiling Han retweeted
In Melbourne, in December, and co-chaired by @CentreImpactAMR Prof Jian Li. You have until end of October to submit your abstract, and until mid-November to register. Great speakers already lined up!
Submit your abstract to the 1st International Conference on Computational Antimicrobial Pharmacology (ICAComp 2022). Program and registration can be found on the official website (icacomp.org).
#Antimicrobial #pharmacology #bioinformatics #MonashUni #MachineLearning
Meiling Han retweeted
📢MEET THE SPEAKER
In this talk, Dr Yu-Wei Lin will introduce different #antimicrobial pharmacometric techniques and highlight the usefulness of pharmacometric analyses in antimicrobial research.
📅25 Aug⏰11.00 CET
tinyurl.com/5cjpjvdv
#IDTwitter #infectiousdiseases #AMR
Meiling Han retweeted
Meeting our brilliant PhD students during a visit to announce the @moderna_tx mRNA production facility @monashuni, many will go on to develop Australia's mRNA and biotech capabilities for the future. More: bit.ly/3bVf4hq and bit.ly/3C5EWln
Meiling Han retweeted
Only 2 days before the PMV Symposium, have you registered yet? Check out the great list of talks below. See you there! #proteomics #metabolomics #multiomics
Meiling Han retweeted
Get ready for our Mid-Year Symposium!! Focusing on all things #multiomics and held at @Bio21Institute with some fantastic speakers. Its free AND hybrid, so you really don't have an excuse not to come. Register now at tinyurl.com/mrxsf3y4! #proteomics #metabolomics #lipidomics
Meiling Han retweeted
Wonderful work from Xukai, @han_meiling and the team.
#AntimicrobialResistance #DrugDevelopment #MonashBDI
pubs.acs.org/doi/full/10.102…
Meiling Han retweeted
With investment, we can fix the problem of #AntimicrobialResistance. BDI's Jian Li & @MIPS_Australia's Tony Velkov in a candid article on how #AMR threatens our health future, as they're on the cusp of achieving something that hasn't been done for decades. abc.net.au/news/2022-05-11/a…
Meiling Han retweeted
Antibiotic resistance is threatening our health. Will bacterial infection send us back to the medical dark age?
@MonashBDI @Qpexbio @monashmicro @MIPS_Australia @MonashUni @Thompson_Chem @MikeMnDudley @NicoVoelcker @JasonJinxin @han_meiling #antibiotics
go.nature.com/3P9mDQi


































